• AIBP-LRP2 Restricts CXCR4+ Collateral Vessel Growth

  2026-09-21

  The reference study identifies an AIBP–LRP2–HDL–miR-223 pathway that suppresses CXCR4+ stemlike capillary endothelial cells and limits collateral circulation after ischemic injury. By combining human PAD profiling with murine genetic and mechanistic experiments, it proposes a two-phase model in which CXCR4+ capillary cells first expand and then acquire arterial characteristics.

• QSHXO in MASLD: Autophagy and Ferroptosis

  2026-09-21

  Liu et al. show that Qushi Huoxue ointment reduces hepatic steatosis, inflammation, and injury in a mouse model of metabolic associated steatotic liver disease while engaging autophagy and suppressing ferroptosis-related signals. The study’s value lies in combining pharmacological profiling, network pharmacology, molecular validation, and ultrastructural analysis to develop a coordinated mechanistic model for further testing.

• DAPI and DNA Dynamics in Pancreatic Organoids

  2026-09-20

  A translational framework for using DAPI (hydrochloride) to quantify nuclear biology, cell-cycle state, and assay quality in pancreatic ductal organoid workflows without confusing DNA measurement with lineage identity.

• 3-Dehydroteasterone Analogues: Assay-Dependent Activity

  2026-09-19

  A 2025 study developed 3-dehydroteasterone analogues bearing 23,24-dinorcholanic side chains and C-22 benzoate groups, then evaluated them with rice lamina inclination and bean second-internode assays. The strongest rice response approached that of Brassinolide, while contrasting bean results demonstrate that structure–activity relationships depend strongly on the bioassay selected.

• ASB3-MAVS Regulation of Antiviral Immunity

  2026-09-18

  A 2024 Cell Death & Differentiation study identifies ASB3 as an inducible E3 ubiquitin ligase that restrains antiviral innate immunity by promoting K48-linked ubiquitination and proteasomal degradation of MAVS. Cellular and animal experiments connect ASB3 activity with reduced type I interferon signaling and increased susceptibility to selected influenza A virus infections, providing a mechanistic framework for studying host regulation of RIG-I-like receptor signaling.

• H-151 Links STING Inhibition to Ferroptosis Control

  2026-09-18

  A study in Cell Chemical Biology reports that H-151, a covalent STING inhibitor, also suppresses ferroptosis through STING-independent radical-trapping antioxidant activity. By combining inflammatory pathway inhibition with protection against lipid peroxidation, H-151 reduced renal ischemia-reperfusion injury in mice, revealing an important mechanism for interpreting this compound in experimental systems.

• GANT61: GLI Inhibitor Workflows for Tumor Studies

  2026-09-17

  GANT61 provides a practical way to interrogate GLI1/2 transcriptional output in tumor-cell, immune-microenvironment, and xenograft workflows. This guide connects dose-response design and pathway validation with the emerging GLI2–WNT–prostaglandin model of immunotherapy resistance.

• Phosbind Acrylamide: Reading Phosphorylation Shifts

  2026-09-17

  Phosbind Acrylamide enables antibody-free protein phosphorylation analysis through phosphorylation-dependent mobility shifts in SDS-PAGE. This article explains how to design, interpret, and extend the assay using mechanistic insights from MDV US3–NF-κB signaling research.

• 6-Thioguanine, DNMT1, and MCF-7 Transcriptomics

  2026-09-16

  The reference study combines transcriptomics with functional assays to show that 6-thioguanine suppresses MCF-7 breast cancer cell growth alongside reduced DNMT1 expression, increased FAS-associated apoptosis, and p21-linked G2/M arrest. Its main value is a mechanism-oriented framework for studying thioguanine beyond leukemia, while its single-cell-line, in vitro design requires cautious interpretation and independent validation.

• Ertugliflozin, Brain Insulin Signaling, and Tau

  2026-09-16

  The reference study tested whether ertugliflozin could reduce Alzheimer’s disease-like pathology caused by disrupted brain insulin signaling. In an intracerebroventricular streptozotocin rat model, treatment improved cognitive performance and biochemical markers linked to cholinergic function, apoptosis, mitochondrial activity, synaptic plasticity, and tau phosphorylation.

• NLRP10, Keratinocyte Survival, and AD Barrier Function

  2026-09-15

  The 2024 Cell Death and Disease study identifies NLRP10 as a regulator of epidermal homeostasis, linking keratinocyte survival with p63-dependent differentiation and barrier integrity. Its human skin models and mechanistic analysis suggest that reduced NLRP10 may connect genetic susceptibility to the barrier defects characteristic of atopic dermatitis.

• ATS-9R: Reliable Adipocyte Gene Delivery

  2026-09-15

  This scenario-driven guide explains how ATS-9R (Adipocyte-targeting sequence-9-arginine), SKU C8721, can improve experimental control in adipocyte viability, proliferation, and gene-silencing workflows. It connects product parameters with published FAM83A research and provides practical guidance for complex formation, assay controls, interpretation, and product selection.

• Ultrafiltration for Circular RNA Purification

  2026-09-14

  Guillen-Cuevas and colleagues show that ultrafiltration can enrich protein-encoding circular RNA from in vitro transcription mixtures containing linear and nicked RNA species. Using polyethersulfone membranes and flux-based process analysis, the study achieved higher reported purity and comparable or better yield than size-exclusion HPLC, supporting ultrafiltration as a scalable research-stage purification strategy.

• Clodronate Liposomes for Macrophage Depletion

  2026-09-14

  Clodronate Liposomes provide a practical loss-of-function strategy for testing whether macrophages drive tissue injury or treatment response. This guide connects route selection, matched controls, depletion verification, and single-cell follow-up to the Tmem176b+ macrophage findings reported in hepatic ischemia-reperfusion research.

• Sumatriptan Metabolism: CYP–MAO Revisited

  2026-09-13

  The reference study revisits the established view that sumatriptan is metabolized mainly through monoamine oxidase A (MAO A). Using recombinant human enzymes and HPLC–MS, it demonstrates CYP-dependent N-demethylation followed by selective MAO A oxidation, providing a more complete framework for interpreting metabolite formation and drug–enzyme interactions.

8080 records 1/539 page Next 12345 下5页 Last page